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Abstract
Background: Shigella dysenteriae serotype 1 (SD1) causes the most severe form of epidemic bacillary dysentery.
Quantitative proteome profiling of Shigella dysenteriae serotype 1 (SD1) in vitro (derived from LB cell cultures) and
in vivo (derived from gnotobiotic piglets) was performed by 2D-LC-MS/MS and APEX, a label-free computationally
modified spectral counting methodology.
Results: Overall, 1761 proteins were quantitated at a 5% FDR (false discovery rate), including 1480 and 1505 from
in vitro and in vivo samples, respectively. Identification of 350 cytoplasmic membrane and outer membrane (OM)
proteins (38% of in silico predicted SD1 membrane proteome) contributed to the most extensive survey of the
Shigella membrane proteome reported so far. Differential protein abundance analysis using statistical tests revealed
that SD1 cells switched to an anaerobic energy metabolism under in vivo conditions, resulting in an increase in
fermentative, propanoate, butanoate and nitrate metabolism. Abundance increases of transcription activators FNR
and Nar supported the notion of a switch from aerobic to anaerobic respiration in the host gut environment. High
in vivo abundances of proteins involved in acid resistance (GadB, AdiA) and mixed acid fermentation (PflA/PflB)
indicated bacterial survival responses to acid stress, while increased abundance of oxidative stress proteins (YfiD/
YfiF/SodB) implied that defense mechanisms against oxygen radicals were mobilized. Proteins involved in
peptidoglycan turnover (MurB) were increased, while b-barrel OM proteins (OmpA), OM lipoproteins (NlpD),
chaperones involved in OM protein folding pathways (YraP, NlpB) and lipopolysaccharide biosynthesis (Imp) were
decreased, suggesting unexpected modulations of the outer membrane/peptidoglycan layers in vivo. Several
virulence proteins of the Mxi-Spa type III secretion system and invasion plasmid antigens (Ipa proteins) required for
invasion of colonic epithelial cells, and release of bacteria into the host cell cytosol were increased in vivo.
Conclusions: Global proteomic profiling of SD1 comparing in vivo vs. in vitro proteomes revealed differential
expression of proteins geared towards survival of the pathogen in the host gut environment, including increased
abundance of proteins involved in anaerobic energy respiration, acid resistance and virulence. The immunogenic
OspC2, OspC3 and IpgA virulence proteins were detected solely under in vivo conditions, lending credence to their
candidacy as potential vaccine targets.
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Background
The Gram-negative bacterium Shigella dysenteriae sero-
type 1 (SD1) is among the most virulent serotypes of the
four Shigella (S.) species (S. dysenteriae, S. flexneri, S. son-
nei and S. boydii). SD1 is a causative agent of shigellosis,
a severe form of epidemic bacillary dysentery in humans
and primates [1,2]. Shigellosis is most prevalent in under-
developed countries, with a mortality rate of 10-15%
when untreated, killing about 1.1 million people of the
roughly 120 million cases each year http://www.who.int/
vaccine_research/diseases/diarrhoeal/en/index6.html.
SD1 has an extremely low infectious dose of 10-100
organisms which has contributed to causing pandemic
Shiga dysentery in several continents including Asia,
Africa and Central America [2]. In addition to having a
low infectious dose, multi-drug antibiotic resistance to
more than six types of antibiotics (tetracycline, strepto-
mycin, chloramphenicol, etc.) has developed in several
Shigella serotypes [3]. S. dysenteriae is also very closely
related to Escherichia (E.) coli, with certain strains of
E. coli (Shiga toxin-producing E. coli, or STEC) produ-
cing the potent Shiga toxins (Stx) of which Stx1 is pro-
duced by SD1 as well [4]. Shiga toxin causes cell death
primarily in the microvascular endothelium. A vaccine
that is protective against Shigella serotypes is of utmost
importance, and several attenuated vaccines are currently
being developed and tested in human volunteers.
Components of the Type Three Secretion System (TTSS)
encoded by a virulence plasmid are also involved in the
pathogenesis of shigellosis [5]. Also called the Mxi-Spa sys-
tem in Shigella, the TTSS is responsible for triggering entry
into host epithelial cells and apoptosis in macrophages
[6,7]. The TTSS is activated upon contact with host cells,
leading to the integration of translocators in the host cell
membranes which then promotes transit of effectors into
host cells [8]. The TTSS and effector proteins thereby play
an important role in infection and intra- and inter-cellular
spreading of bacterial cells in the host intestinal epithelium
[9]. O-antigens present in the cell surface lipopolysacchar-
ide (LPS) of Shigella also contribute to its virulence [2]. The
Shigella O-antigen comprises of a toxic lipid A moiety
embedded in the bacterial outer membrane, a core sugar
region and an exposed terminal O-polysaccharide. In SD1,
the O-polysaccharide consists of tetrasaccharide repeats
that contain repeat units of three rhamnose residues
and one N-acetylglucosamine [2]. Enzymes essential for O-
antigen biosynthesis are mostly encoded by chromosomal
genes such as galETKM and rfbBDACX [10]. The terminal
O-polysaccharide structures vary greatly among Shigella,
thereby giving rise to the immunological specificity that has
resulted in distinct serotypes. Although attenuated Shigella
strains expressing genetically engineered O-antigens have
been tested as vaccine candidates, an effective vaccine
against Shigella remains elusive [2], possibly due to the
diversity of the O-antigens.
Comprehensive proteomic profiling has the potential to
identify novel virulence factors in Shigella that could form
potential vaccine or therapeutic targets. Proteomic surveys
of Shigella have mainly focused on S. flexneri, which
causes endemic shigellosis. Extensive 2D-LC-MS/MS-
based profiling of the S. flexneri membrane proteome by
Wei et al. resulted in the identification of more than 600
S. flexneri proteins including ca. 200 integral and outer
membrane proteins [11]. Immunoproteome analyses of S.
flexneri identified several membrane proteins as being
antigenic including OmpA, IpaD, Spa33, TolC and YaeT
[12,13]. The S. dysenteriae strain Sd197 was the first
S. dysenteriae genome to be sequenced [14], and included
sequences of the chromosome, a large virulence-associated
plasmid (pSD1_197) and a small plasmid (pSD197_Spa).
This annotated SD1 genome was exploited in a compre-
hensive proteomic survey of S. dysenteriae strain Sd1617
via 2D gel electrophoresis which resulted in the identifica-
tion of 1061 distinct gene products [15]. Immunopro-
teome analysis of SD1 Sd1617 identified seven proteins
including type III secretion system effectors OspC2 and
IpaB as antigens. In this report, a quantitative global pro-
teomic analysis of SD1 cells grown to stationary phase in
culture (in vitro) vs. SD1 cells isolated from mammalian
host environment (in vivo) was performed using 2D-LC-
MS/MS and APEX, a label-free computationally modified
spectral counting method [16]. Data from the SD1 in vitro
and in vivo proteomes was analyzed for differential protein




All reagents for protein extraction from cell lysates and
protein analysis by mass spectrometry (MS) were used as
previously described [15,17]. RNase, DNase I (bovine pan-
creas), triethyl ammonium bicarbonate (TAB) buffer used
for tryptic digestion, TCEP (Tris(2-carboxyethyl)phos-
phine) used as a reducing agent and the bicinchoninic acid
(BCA) protein assay kit to estimate protein concentrations
were purchased from Sigma-Aldrich (St. Louis, MO). The
alkylating agent MMTS (methyl methanethiosulfonate)
was purchased from Pierce (Rockford, IL). Sequencing
grade porcine trypsin was obtained from Promega (Madi-
son, WI). Triton X-100 was purchased from Calbiochem
(LaJolla, CA). SDS-PAGE was performed according to
instructions from Invitrogen.
Bacterial strains and culture conditions
The strain Sd1617 of Shigella dysenteriae serotype 1
(SD1) strain was grown on tryptic soy agar plates (TSA)
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containing 0.05% Congo Red (w/v). SD1 in vitro samples
were prepared by inoculating a single colony into Luria-
Bertani (LB) medium grown to stationary phase at 37°C
with agitation. The bacteria were harvested by centrifu-
gation and washed twice with ice-cold PBS (6,000 × g,
15 min) at 4°C.
The inoculum for in vivo experiments was prepared by
growing a typical SD1 colony selected from a TSA plate
in LB medium overnight. Gnotobiotic piglets used for
the animal experiments were delivered by Caesarian sec-
tion at Tufts University Cummings School of Veterinary
Medicine. Of several animals inoculated with SD1, three
piglets were chosen for isolation of SD1 bacterial cells
from the intestine in this comparative study. One of the
piglets inoculated with 1 × 108 SD1 cells developed diar-
rhea 24 h later and was euthanized 4 d later when the
gut contents were collected for bacterial purification.
Another piglet inoculated with 5 × 108 SD1 cells devel-
oped diarrhea within 18 h and was euthanized 3 d post-
inoculation. A third piglet inoculated with 5 × 109 SD1
cells developed diarrhea within 20 h and the gut con-
tents collected 2 d post-inoculation. SD1 bacterial cells
were isolated from the gut contents as described pre-
viously [15]. Briefly, the gut contents from cecum and
colon were pooled and transferred to sterile histological
cups placed on ice, suspended in ice-cold PBS at 4°C
and pelleted at 5,000 × g. After resuspension of the pel-
let in 65% isotonic Percoll solution and centrifugation at
14,500 × g, the bacterial layer near the bottom was col-
lected using a 3-5 ml syringe with needle. The bacteria
were washed twice with ice-cold PBS at 4°C and pro-
cessed for proteomic analysis.
Lysis of S. dysenteriae cells and trypsin digestion of
extracted proteins
After the PBS wash steps, bacterial cell pellets from in
vitro or in vivo culture conditions were re-suspended in a
hypotonic lysis buffer composed of 25 mM Tris-HCl (pH
7.8) with 150 μg/mL lysozyme, 0.05% Triton X-100,
5 mM EDTA, protease inhibitors (1 mM benzamidine
and AEBSF) for 30 min at room temperature (RT) with
gentle agitation. The samples were then placed at -80°C
until further processing. For nucleic acid digestion, bac-
terial samples suspended in the lysis buffer were thawed
and gently agitated for 1 h at RT after the addition of
DNase I, RNase and leupeptin (10 μg/mL each) and
20 mM MgCl2. Cell lysates were centrifuged at 16,000 ×
g for 30 min at 4°C, and the supernatants containing bac-
terial cell lysate proteins were recovered.
Following cell lysis, the extracted bacterial proteins
were precipitated in six volumes of ice-cold acetone at
-20°C for at least 1 h. Acetone-precipitated proteins were
recovered as a pellet after centrifugation at 5,000 × g for
10 min. The protein pellet was resuspended in 0.1 M
TAB buffer, pH 8.5, and the total protein concentration
measured using the BCA assay. Proteins were denatured
in 0.1% SDS and reduced using 5 mM TCEP for 1 h at
37°C, followed by alkylation using 10 mM MMTS for 1 h
at RT [18]. In-solution trypsin digestion of the complex
protein mixture was performed by the addition of trypsin
at 1:25 for 5 h at 37°C followed by 1:50 digestion over-
night. The tryptic digested samples were applied to SDS-
PAGE to check for extensive digestion.
Mass spectrometry analysis of tryptic peptides
Methods for mass spectrometry (MS) analysis were pre-
viously described in detail [17]. Briefly, tryptic peptide
digests (ca. 100 μg) were fractionated by 2D-LC-MS/MS,
first using a Polysulfoethyl-A SCX column (4.6 × 50 mm,
Nest Group, USA) followed by an Agilent 1100 series sol-
vent delivery system (Agilent, Palo Alto, CA) online with
a nano-electrospray LC-MS/MS system (LTQ-IT mass
spectrometer, Thermo-Finnigan, San Jose, CA). SCX
fractions were delivered from 96-well plates onto a Pico-
Tip microcapillary reversed-phase column (BioBasic C18,
75 μm × 10 cm, New Objective, Woburn, MA) at a flow
rate of 350 nL/min. Spectra were acquired in automated
MS/MS mode with the top five parent ions selected for
fragmentation using collision energy of 35%. LC-MS/MS
was performed in three sequential m/z subscans (300-
650, 650-900, 900-1500 m/z) to increase the sampling
depth [16].
MS and MS/MS data from sequential runs were com-
bined for search against the latest release of the S. dysen-
teriae Sd197 genome database in NCBInr using the
Mascot search engine v.2.2 (Matrix Science, London,
UK). This database contained 4502 protein sequences,
including 231 proteins encoded by the two SD1 plasmids.
Mascot search parameters allowed for tryptic specificity
of up to one missed cleavage, with methylthio-modifica-
tions of cysteine as a fixed modification and oxidation of
methionine as a variable modification. The LTQ search
parameters for +1, +2 and +3 ions included mass error
tolerances of ± 1.4 Da for peptide ions and ± 0.5 Da for
fragment ions. The false discovery rate (FDR) for peptide
identifications was determined using the Mascot decoy
database search option, with searches against a rando-
mized S. dysenteriae Sd197 protein decoy database. Mas-
cot search results of replicate 2D-LC-MS/MS
experiments were further validated by estimating the
FDR [19]via PeptideProphet™ and ProteinProphet™
[20] which are part of the Trans-Proteomic Pipeline
(TPP) available at http://tools.proteomecenter.org/wiki/
index.php?title=Software:TPP.
APEX quantitation of SD1 cell lysate LC-MS/MS datasets
APEX quantitation of SD1 proteins was performed using
the APEX Quantitative Proteomics Tool [21]v.1.1 as
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described previously [17]. Briefly, three steps were per-
formed, building a SD1 training dataset, computing SD1
protein Oi (expected number of unique proteotypic pep-
tides for protein i) values, and calculating SD1 protein
APEX abundances. Proteins in the training dataset were
comprised of the 100 most abundant SD1 proteins
based on high spectral counts per protein and high pro-
tein and peptide identification probabilities [22]. The
training dataset. ARFF file was constructed based on 35
peptide physicochemical properties deemed significant
for the computational prediction of proteotypic peptides
[16,23]. To compute SD1 protein Oi values, the Random
Forest classifier algorithm was applied to the SD1 train-
ing dataset constructed in the previous step, and then to
all tryptic peptides generated in silico from the SD1 pro-
teome to enable computation of SD1 protein Oi values.
APEX abundances of the SD1 proteins observed by 2D-
LC-MS/MS were calculated using the protXML files
generated from the PeptideProphet™ and ProteinPro-
phet™ validation of the Mascot search results and the
SD1 protein Oi values. While data from the technical
replicates (three to five) for each of the three biological
samples were pooled in the analysis, data from the bio-
logical replicates were analyzed separately under in vitro
and in vivo conditions. A <5% FDR was chosen, along
with a normalization factor of 2.5 × 106. The normaliza-
tion factor in the APEX tool is equivalent to the term C
in the APEX equation [16], which represents the total
concentration of protein molecules per cell. Since S. dys-
enteriae is closely related to E. coli, the total number of
protein molecules/cell estimated at 2-3 × 106 for E. coli
[16] was used as a normalization factor in the APEX
abundance measurements of S. dysenteriae proteins.
Bioinformatic analysis tools
In silico predictions of subcellular protein localizations
were obtained using PSORTb v.2.0 searches [24] of the
S. dysenteriae Sd197 proteins. In cases where the
PSORTb analysis was inconclusive, the datasets were
queried by five other algorithms (SignalP [25], TatP
[26], TMHMM [27], BOMP [28] and LipoP [29]) to pre-
dict motifs for export signal sequences, TMD proteins
and lipoproteins in SD1 proteins.
Statistical analysis, clustering and pathway analysis of
SD1 proteomic datasets
Differential protein expression analysis of the in vitro vs.
in vivo proteomes was examined using a two-tailed
Z-test [16] incorporated into the APEX tool [21]. The
p-values from the Z-test obtained for the proteins com-
mon to the in vitro and in vivo samples were subjected
to the Benjamini-Hochberg (B-H) multiple test correc-
tion available from the open source R statistical package
http://www.r-project.org to estimate the false discovery
rate (FDR). Further statistical analysis and clustering of
the data were performed using the MeV v.4.4 (Multiex-
periment Viewer) software tool, an application designed
for detailed statistical analysis of large-scale quantitative
datasets [30,31]. A two-class SAM (Significance Analysis
for Microarrays) was performed, and a heat map gener-
ated by clustering the data using HCL (Hierarchial Clus-
tering) and Euclidean distance in MeV. To determine
the reproducibility of the datasets, a pairwise Pearson’s
correlation plot was constructed to correlate protein
abundance values obtained for each protein from repli-
cate analyses. For pathway analysis, the S. dysenteriae
Sd197 KEGG pathway was obtained from the KEGG
database [32]. The KEGG pathway was loaded into Kat-
sura v.1.0 (JCVI), which is an open source software
application for exploring the KEGG metabolic pathway
coverage and expression available at http://pfgrc.jcvi.org/
index.php/bioinformatics/katsura.html. To identify the
SD1 metabolic pathways and functional proteins that
were altered under in vivo conditions as compared to in
vitro conditions, each pathway was examined for pro-
teins exhibiting higher or lower protein abundance
values based on the two-tailed Z-test analysis.
Results and Discussion
Global profiling of S. dysenteriae strain Sd1617 in vitro
and in vivo proteomes
Shigella dysenteriae serotype 1 (SD1), which possesses
the cytotoxic Shiga toxin (Stx), causes deadly epidemics
in many poor countries [14]. However, no effective vac-
cine for this pathogenic organism is currently available
although there are several attenuated strains at different
stages of development [2]. Proteomic analysis of S. dys-
enteriae is a strategy to identify novel vaccine and thera-
peutic drug targets. A gnotobiotic piglet model was
recently developed [33] to serve as an alternative to a
primate model to study infections with the highly host-
specific pathogen S. dysenteriae [15,34]. SD1 bacterial
cells were collected from stationary phase suspension
cultures in LB broth (referred to as ‘in vitro’) and from
the gut of several infected gnotobiotic piglets (referred
to as ‘in vivo’). The lack of microflora in gnotobiotic ani-
mals and the ability to recover more than 109 purified
SD1 bacteria from in vivo conditions allowed unique
studies of the nature of the pathogen’s direct interaction
with the host tissue in the absence of other interfering
microflora.
A preliminary 2D gel-based survey of the SD1 proteome
from the piglet intestinal environment was reported pre-
viously [15]. Here, the scope of the differential proteomic
analysis was expanded using three to five technical and
three biological replicates from both in vitro and in vivo
groups. We resorted to a strategy combining the benefits
of 2D-LC-MS/MS for a comprehensive coverage of
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proteins, and APEX (a modified spectral counting method
for protein expression measurements derived from LC-
MS/MS datasets). The in vitro analysis resulted in the
identification of 1480 proteins while the in vivo analysis
identified 1505 proteins at a 5% false discovery rate (FDR).
1224 proteins were common to both samples, with 256
and 281 proteins unique to the in vitro and in vivo ana-
lyses, respectively (Figure 1). Genome sequencing of
the strain Sd197 suggested 4271 chromosomal ORFs, 223
plasmid pSD1_197-encoded ORFs and 8 plasmid
pSD197_spA-encoded ORFs [14]. Combining LC-MS/MS
data from all experiments and assuming a 5% FDR, 1761
proteins comprising 39% of the SD1 proteome were iden-
tified across a wide Mr (4.3 - 176.5 kDa) and pI (3.59 -
11.84) range (Additional File 1, Table S1). 105 and 95
proteins were identified based on a single peptide match
from the in vitro and in vivo analyses, respectively. Since
small or low abundance proteins are frequently identified
by one or two peptides [19], validation of the single pep-
tide match proteins was performed by validating the spec-
trum manually. Of the 231 proteins encoded by the two
plasmids pSD1_197 and pSD197_spA, 66 and 3 proteins
were identified, respectively. This included 15 Mxi-Spa
proteins and 16 effectors/chaperones of the type III secre-
tion system (TTSS) clustered in the ipa gene locus of
pSD1_197. Wei et al. [11] identified 45 of the orthologous
S. flexneri proteins expressed from the plasmid pCP301,
including 8 Mxi-Spa proteins and 11 effectors/chaperones.
The comparison supports the notion that expression of
these genes is important in the proper functioning of the
TTSS of both Shigella species.
Subcellular localizations (SCL) of all 1761 identified SD1
proteins were determined, either based on in silico predic-
tions by the tool PSORTb or by the combination of short
motifs recognized in protein sequences by six different
algorithms (SignalP, TatP, TMHMM, BOMP, LipoP and
KEGG pathway role). Data from the latter categorization
are displayed in Figure 2, with most proteins (1310) being
assigned to the cytoplasm. As membrane proteins are
often of particular interest in the context of virulence, they
were also selectively surveyed in a study on S. flexneri 2a
[11], yielding approximately 35 outer membrane (OM)
and 159 integral cytoplasmic membrane (CM) proteins.
SCL prediction of our data yielded 350 membrane pro-
teins (including 108 OM and 242 CM proteins), contribut-
ing to an extensive survey of the Shigella membrane
proteome. Many peripheral, integral and lipid-anchored
membrane proteins could also be quantitated applying the
APEX tool. This is a marked advantage of 2D-LC-MS/MS
over 2D gel-based proteomic surveys. For example, we
were able to obtain quantitative estimates for numerous
membrane proteins, some of them part of complexes. This
included 7 of the 8 F0F1 ATP synthase subunits predicted
for SD1 http://biocyc.org, 11 of the 13 NADH dehydro-
genase (Nuo) subunits, all three formate dehydrogenase
subunits (FdoG/H/I), all four cytochrome oxidase subunits
(CydA/B/C/D), b-barrel OM porins (OmpA, OmpC,
OmpX), multidrug efflux transporters (MdlA, MdlB,
Figure 1 Euler/Venn diagram representations of S. dysenteriae
serotype 1 (SD1) proteins. Of the 4502 proteins predicted for the
SD1 genome, 1761 proteins were identified at a 5% false discovery
rate (FDR), with 1480 proteins identified from the in vitro analysis,
and 1505 proteins from the in vivo analysis.
Figure 2 Sub-cellular localization (SCL) of SD1 proteins. SCL of
4502 proteins encoded by the SD1 genome was predicted using
the bioinformatic algorithms PSORTb, SignalP, TatP, TMHMM, BOMP,
LipoP and KEGG. 350 outer and inner membrane proteins
corresponding to ca. 38% of the SD1 membrane proteome, and
1410 cytoplasmic and periplasmic proteins representing ca. 39% of
SD1 soluble proteins were identified.
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YdhE, YhiU, EmrA, EmrY) and 15 structural components
of the bacterial Mxi_Spa apparatus. Most proteins or their
orthologs which were described as being immunogenic
by Ying et al. [12,35] in S. flexneri and Pieper et al. in S.
dysenteriae (15), were also identified in this SD1 dataset
(OmpA, YaeT, OppA, DnaK, ClpB, Pgm, AtpA, AtpD,
LpdA, Gnd, Tst, MglB, FusA, ManX, TolC, UshA, OspC2,
VirB and IpaB).
Highly abundant SD1 proteins, in vivo and in vitro, were
implicated in energy/carbon metabolism and protein
synthesis. This included glycolytic enzymes (PckA, GapA,
Tpi, Fba, Pgk, GpmA, Eno), elongation factors (FusA,
TufA, Tsf), several ribosomal protein subunits (RpsD/K/
M, RplC/D/E, RpmC/D/J), and stress response proteins
(WrbA, AhpC, SodB). Proteins with global regulatory
functions in the cellular stress response were identified in
vivo as well as in vitro (Hns, RpoS and CpxR). In sum-
mary, SD1 cells produced proteins essential for growth
and cell integrity (energy generation, protein synthesis, cell
envelope structure) as well as response to cellular and
environmental stresses in high abundance.
Differential abundance analyses of the SD1 in vitro and in
vivo proteomes
Data from three biological replicates pertaining to in vivo
and in vitro conditions were subjected to statistical ana-
lyses. The biological replicate analyses were pooled for the
Z-test, and analyzed separately by the SAM test. Differen-
tial expression analysis of the in vitro vs. in vivo proteomes
using a two-tailed Z-test resulted in ca. 300 proteins iden-
tified as being differentially abundant at a 99% confidence
level (Figure 3), while the SAM test identified ca. 90 differ-
entially expressed proteins (Additional File 2, Table S2).
As the SAM test takes into account the biological variabil-
ity between replicates, it is more conservative at estimating
the differential protein expression given the dynamic range
of the biological data which may inflate variance measures.
The Benjamini-Hochberg (B-H) multiple test correction
performed on the 1224 proteins common to the in vitro
and in vivo samples estimated the FDR at <5% for the ca.
300 differentially expressed proteins identified from the
Z-test (Additional Files 1 and 2, Tables S1 and S2). Hierar-
chial clustering of the data resulted in several major clus-
ters of similarly expressed proteins (Figure 4). Selection of
two clusters magnified in Figure 4 was based on biological
interest in the set of proteins that exhibited differential
abundance values. For example, one of the clusters har-
bored numerous ribosomal proteins and several Ipa/Ipg
host cell invasion proteins, all of which were clearly
increased in abundance in vivo. Another cluster harbored
several enzymes indicative of the shift from aerobic to
anaerobic energy generation. Protein functional role cate-
gories of the differentially expressed proteins were
assigned according to the CMR database http://cmr.jcvi.
org and are displayed in Figure 5. Several cellular pro-
cesses appeared to be activated in the intestinal environ-
ment comparing the percentage of abundance-changed
proteins per role category in both the in vitro (Figure 5a)
and the in vivo (Figure 5b) groups. Most striking were the
changes in protein synthesis (0.6% vs. 18.1% in vitro and in
vivo, respectively) and purine, pyrimidine and nucleotide
biosynthesis (1.2% vs. 5.8%). In contrast, activity decreases
in vivo were denoted for regulatory processes (4.9% vs.
1.8%), cell envelope functions (5.6% vs. 2.3%) and transport
(10.5% vs. 7%). Overall, the graphic in Figure 5 clearly
illustrates that the SD1 cells adapt to the host intestinal
environment by alternating a multitude of their cellular
pathways and processes.
Differential expression analysis of the APEX datasets
revealed several biochemical processes that appeared to
be important for the pathogen to infect the piglets and
to survive in their intestinal environment. Strongly
altered abundances in the in vivo environment pertained
to proteins involved in mechanisms of acid resistance
(GadB, AdiA, HdeB, WrbA), the switch from aerobic to
anaerobic respiration and mixed acid fermentation
(PflA, PflB, PykF, Pta), oxidative stress (YfiD, YfiF,
SodB) and other general cellular stress responses invol-
ving cold and heat shock proteins (CspA, CspE, ClpB).
The in vivo responses suggested enhanced bacterial
stress under oxygen- and nutrient-limited conditions in
Figure 3 SD1 differential protein expression analysis using the
two-tailed Z-test. Approximately 300 proteins were found to be
differentially expressed at 99% confidence, including 151 in vivo and
142 in vitro SD1 proteins using the two-tailed Z-test utility in the
APEX tool application.
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the host gut environment. In contrast, the in vitro pro-
teome was defined by high abundances of enzymes
involved in fatty acid oxidation (FadA, FadB, FadD, etc.)
and aerobic respiration (GltA, IcdA, SdhA, SucA, etc.).
Several proteins linked to the type III secretion appara-
tus were increased in abundance, or found solely under
in vivo conditions including chaperones for effector pro-
teins (IpgA/B/C/D/E), transcription activators (VirB),
translocators (IpaA/B/C/D) and effectors (IcsB, VirA,
OspF).
Transition from aerobic to anaerobic respiration and
fermentation in SD1 bacterial cells in vivo
The pathogenic S. dysenteriae is a facultative anaerobe
which can switch to an anaerobic energy metabolism
when starved of oxygen in the host large intestine. Pro-
teins involved in energy metabolism formed the largest
category of abundance-changed proteins under both in
vitro and in vivo conditions (Figure 5), indicative of the
impact of the intestinal environment on the SD1 cell’s
energy generation pathways. We have previously
reported in a 2D gel-based proteomic analysis that the
intestinal environment resulted in a shift from aerobic
respiration to fermentation in SD1 cells (15). A more
comprehensive dataset was obtained in this study and
highlights the advantages of 2D-LC-MS/MS and APEX
over differential 2D gel display. The former approach is
not only more sensitive, as it strongly increased the
number of profiled low abundance proteins, but also
revealed marked advantages via the quantitation of
hydrophobic CM and OM proteins.
It was confirmed that most of the tricarboxylic acid
(TCA) cycle enzymes were strongly decreased in SD1
cells in vivo, such as GltA, IcdA, SucA, SucB, SucC,
SucD, SdhA, SdhB and Mdh. The abundance changes of
these and following enzymes are provided in Additional
File 1, Table S1. The TCA cycle was clearly less active
under anaerobic (in vivo) than aerobic/microaerophilic
Figure 4 Hierarchial clustering (HCL) analysis of differentially expressed SD1 proteins based on APEX abundance values using MeV.
Protein abundance values from the in vitro sample are represented on the left, with in vivo protein abundances on the right. Abundance
magnitude is depicted as a color gradient, with red indicating an increase in protein abundance, green indicating a corresponding decrease in
abundance, and black for the median level of abundance. Based on biological interests, example clusters are enlarged to depict differentially
expressed proteins.
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(in vitro) conditions. New evidence was obtained that
the major enzyme complex contributing electron donors
in the aerobic respiratory chain, NADH:ubiquinone
dehydrogenase I, was markedly less active in vivo.
Nearly all of the subunits (NuoA/B/C/E/F/G/H/I/K/L/
N) were decreased in abundance in vivo. Likewise, a sec-
ond major electron donor enzyme complex known to be
active under aerobic conditions in E. coli, succinate
dehydrogenase, featured strong decreases in vivo (SdhA/
B/C/D). The cytochrome b562 protein CybC was also
strongly decreased in vivo.
The question arose as to which electron donor com-
plexes substituted for Sdh and Nuo in vivo to support
anaerobic and microaerobic respiration. Surprisingly,
subunits of formate dehydrogenase (FdoG/H/I) were
moderately decreased in abundance in vivo, whereas
Fdn was not detected at all. Fdn is purportedly a selec-
tive electron donor for anaerobic respitration http://eco-
cyc.org. FNR (fumarate and nitrate reductase regulator)
and NarP, both components of the complex regulatory
system of respiratory enzymes, were increased in abun-
dance in SD1 cells in vivo. FNR also activates sRNAs
that degrade mRNAs coding for proteins involved in
aerobic respiration [36]. This data supported the notion
that major metabolic shifts in aerobic/anaerobic respira-
tion were regulated at the post-transcriptional level.
Periplasmic nitrate reductase, the Nap complex, was
strongly increased in vivo upon comparing the abun-
dances of the subunits NapA, NapB and NapC. In
E. coli, Nap was shown to be induced under anaerobic
conditions and also regulated by FNR and NarP [37].
Nap appears to act as an electron acceptor under low
nitrate conditions in E. coli, suggesting a similar func-
tion in SD1. The nitrite reductase (NirB/NirD) was also
increased in vivo. This complex has been associated
with nitrite detoxification and appears to be metaboli-
cally linked to the activity of the periplasmic Nap
protein.
Low abundance of electron donors of respiratory com-
plexes was indicative of a switch to mixed acid fermenta-
tion in vivo. Indeed, proteomic evidence strongly
supported the assumption that mixed acid fermentation
and substrate level phosphorylation substituted for the low
abundance of electron donors. Dramatic increases were
noted for subunits of pyruvate formate lyase complexes.
This included the activating enzyme PflA, formate acetyl-
transferases (PflB, TdcE), a putative formate acetyltransfer-
ase YbiW, and the stress-induced alternate pyruvate
formate lyase YfiD. Other mixed acid fermentation
branches also appeared to be more active in vivo, such as
the one initiated by PykA/PykF, which is coupled to acet-
ate secretion via the phosphate acetyltransferase (Pta) and
acetate kinase (AckA) activities. Interestingly, the fermen-
tation/respiration switch protein FrsA was increased in
abundance in vivo. In summary, this data provided com-
prehensive molecular evidence for the shift from aerobic/
microaerobic respiration to fermentation in SD1 cells in
the host intestinal environment.
Fermentation pathways and associated stress responses
have been characterized in E. coli [38]. The dramatic
quantitative increase of YfiD is indicative of the fact that
the glycyl radical protein is a key enzyme required to
Figure 5 Representation of functional role categories of SD1 proteins. Proteins identified from 2D-LC-MS/MS experiments of S. dysenteriae
cells were analyzed based on protein functional assignments in the CMR database for the genome of SD1 strain Sd197. Distribution of role
categories of SD1 proteins cultured from stationary phase cells (in vitro) are shown in the panel on the left (5A) and cells isolated from gut
environment of infected piglets (in vivo) are depicted on the right (5B).
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maintain the activity of PflA/PflB. YfiD has also been
linked to low pH stress; the notion that this protein is
essential for the survival of Shigella in the host gastroin-
testinal environment is intriguing, and makes YfiD a pro-
spective drug target. The E. coli YfiD was also reported
to be induced under acidic conditions in vitro [39]. The
stress-induced alternate pyruvate formate-lyase YfiD
appears to replace PflB upon oxidative inactivation dur-
ing oxidative stress conditions in E. coli [40], thus sup-
porting a critical metabolic role of the pyruvate-formate
lyase PflA/YfiD in SD1 cells in vivo. Other mixed acid
fermentation branches operating in vivo included reduc-
tive pathways for lactate and ethanol, each generating
NAD+ from NADH. In summary, survey of proteomic
data supports strong activity increases in mixed acid fer-
mentation, whereas the TCA cycle and aerobic processes
were decreased correspondingly in SD1 cells localized in
the anaerobic piglet intestine environment.
Response of SD1 cells in vivo to acid stress and toxic
conditions
Acid resistance systems enable the survival of commensal
and pathogenic E. coli strains in the acidic stomach and
host intestinal environment, and neutralize intracellular
acidic fermentation products [41,42]. Strong abundance
changes of several SD1 enzymes contributing to pH
homeostasis in this pathogen were identified in a recent
study (15). This data lends further credence to the impor-
tant function of two acid resistance (AR) systems, AdiA/
AdiC and GadB/GadC, to maintain the intracellular pH
in SD1 cells during gastric passage and, possibly, as a
result of increased generation of acidic fermentation pro-
ducts in the intestine. The orthologous AR systems were
previously characterized in E. coli [42]. While increases
of AdiA were strong in vivo, they also revealed variability
comparing the piglet-derived samples (Additional File 3,
Table S3). Of the transcription factors GadX, EvgA and
YdeO, all reported to influence expression of acid resis-
tance genes [42,43], EvgA was increased in vivo suggest-
ing a key regulatory role of EvgA during acidic stress in
SD1. As also reported earlier (15), two periplasmic acid
resistance chaperones (HdeA, HdeB) which protect peri-
plasmic proteins from aggregation and denaturation at
low pH were increased in SD1 cells in vivo. Hde proteins
expose hydrophobic protein surfaces at low pH and initi-
ate formation of aggregates with denatured periplasmic
protein substrates [44,45].
Host invasion by SD1 implicates the invasion and
release from gut epithelial cells and cells of the innate
and adaptive immune systems. SD1 cells are exposed to
toxic molecules produced and secreted by cells of the
immune system. We mined proteomic data for indica-
tors of the molecular response to toxins. The most intri-
guing finding was the high abundance of nitric oxide
(NO) dioxygenase (HmpA) detected only under in vivo
conditions. NO is known to be produced in large quan-
tities in macrophages and is toxic to intracellular bac-
teria. In M. tuberculosis, the nitric oxide dioxygenase
HbN was shown to be important for nitrite detoxifica-
tion [46]. A hydroxylamine reductase, YbjW, also sca-
venges toxic by-products of nitrogen metabolism and
was detected only in vivo in SD1 cells. We speculate
that the expression of these SD1 enzymes reflected
memory of a previous intracellular life stage. Both
enzymes are interesting targets for inhibitory drug
design. To cope with oxidative stress, SD1 cells dis-
played increased abundances of superoxide dismutases
(SOD) whose expression has been linked to oxygen
availability in E. coli in vivo [47]. The previously men-
tioned regulator FNR and FNR-dependent small RNAs
appear to be implicated in oxygen-dependent SOD
abundance changes [48]. SodA and SodC were
decreased in vivo, while iron-dependent SodB was
clearly increased in vivo. An increase was noticed as
well for the alkyl hydroperoxide reductase subunits
AhpF/AhpC in vivo. The AhpC/AhpF subunits have also
been implicated in the S. typhimurium defense in the
macrophage environment [49]. The immune system in
higher organisms including mice and humans generates
reactive oxygen species, such as superoxide and peroxide
ions to destroy invading microbes [50,51]. The increased
abundance of oxidative stress proteins in vivo therefore
implied a link to bacterial survival through evasion of
the host immune response targeted against intestinal
pathogens. Among the most dramatic abundance
changes were those of three cold shock proteins (CspA,
CspC and CspE). While the exact functions of these low
Mr proteins are not known, a recent study suggested
that csp gene mutants reduced Listeria monocytogenes
invasiveness [52], raising the question of their roles in
epithelial or macrophage cell invasion by SD1. The dra-
matic abundance change of CspA (in vivo vs. in vitro)
makes this protein a particularly interesting target for
further characterization. Heat shock proteins (DnaK,
IbpA, HtpG, GrpE) and chaperones (HslU/HslV, ClpB/
ClpX) were also increased, indicative of further intracel-
lular stress responses by the SD1 cells in vivo. In sum-
mary, we gained insight into protein expression changes
likely required for the survival of S. dysenteriae during
oxidative and acid stress in the host intestine.
SD1 outer membrane and cell surface proteome
A large number of known or predicted b-barrel OM
proteins were altered in abundance comparing in vivo
and in vitro samples (OmpA, OmpC, IcsP/OmpT,
OmpW/YciD, YaeT, Tsx, Lpp). Many of those proteins
are either known or assumed to be exposed at the cell
surface. A large number of lipoproteins sorted into the
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OM were also decreased in abundance under in vivo
conditions (YoaF, LolB, SlyB, YcfM, NlpB, YfgL, NlpD).
Proteins comprising the outer membrane YaeT protein
assembly complex were decreased in abundance (YaeT,
NlpB, YfgL) suggesting that the rate of biosynthesis and
incorporation of the OM proteins was substantially
decreased in vivo. Some of the chaperones presumably
involved in OM protein transit and folding (YraP, HlpA,
YtfJ), all part of RpoE regulon, were also decreased in
abundance in vivo supporting the notion of reduced
OM proteome turnover and a stress environment very
different from that of stationary phase cells in vitro.
Furthermore, components of the OM lipid asymmetry
complex (YrbD, YrbF) and its regulator YrbA were
decreased in abundance in vivo. This complex is a phos-
pholipid transporter responsible for the balance of phos-
pholipids and lipopolysaccharides in the outer leaflet of
the OM. The outer membrane protein Imp directing the
assembly of lipopolysaccharides was also decreased,
while LolD, involved in translocation of OM lipopro-
teins, and the lipoprotein Nlpl (YhbM) were detected
only in vitro. These changes, structurally or functionally
associated with the OM, suggest a remodeling of the
OM-associated cell surface, comprised of lipids, lipopo-
lysaccharides and surface proteins, and a decreased
turnover of proteins in the OM. Interestingly, the tran-
scription factor BolA which regulates the transcription
of genes involved in the morphology of the cell to con-
fer cell protection was substantially decreased in vivo.
Two other proteins likely involved in cell morphology
and peptidoglycan turnover were also decreased in
abundance under in vivo conditions, the rod-shape
determining membrane protein YfgA and the LysM
domain protein YgaU. It remains to be demonstrated
whether these changes represent a coordinated physiolo-
gical response of SD1 cells to the hostile environment in
the host gut, possibly promoting evasion from the
immune system and lowering OM porosity for protec-
tion from any extracellular toxic substances released by
the host.
S. dysenteriae type III secretion system and other
virulence factors
The virulence plasmid encodes the 30 kb spa-mxi type
III secretion system (TTSS) and invasion plasmid anti-
gens (Ipa proteins) required for invasion of host cells
[53]. The TTSS is comprised of a membrane-spanning
protein complex which includes ca. 50 proteins, includ-
ing Mxi and Spa proteins involved in assembly and reg-
ulation of the TTSS, chaperones (IpgA, IpgC, IpgE and
Spa15), transcription activators (VirF, VirB and MxiE),
translocators (IpaB, IpaC and IpaD) and ca. 25 effectors
[8,54]. Invasion is followed by entry of Shigella into
colonic epithelium cells via the basolateral membrane.
Further bacterial invasion and lateral spreading of the
bacteria within the colonic epithelium is mediated by
host cell actin polymerization. The surface protein IcsA
encoded by the virulence plasmid is responsible for
actin-based motility required for intra- and inter-cellular
spread of the bacteria [55]. Shigella manipulates the
host innate and adaptive immune system via the Osp
family of proteins [56].
In the present study, we identified many components
of the TTSS, including 15 Mxi-Spa proteins and 16
effectors and their chaperones (Additional File 1, Table
S1). The TTSS has been reported as being assembled
with a few effectors and chaperones when cultured in
vitro, and activated only after contact of bacteria with
host cells [8]. Here, many TTSS proteins were identified
in both the in vitro and in vivo datasets, including mem-
brane associated Mxi and Spa proteins, Ipa effectors and
Spa chaperones. Spa15 is a chaperone for the Osp family
of effectors (OspC1, OspC2, OspC3) and also for the
IpaA and IpgB2 effectors; while IpgC is a chaperone for
IpaB and IpaC [8]. Activation of TTSS results in the
induction of the transcription of genes encoding a sec-
ond set of effectors under the control of MxiE and
IpgC, including several spa genes. The OspC2 and
OspC3 effectors and the IpgA and Spa32 proteins were
detected only under in vivo conditions. Activation of the
TTSS is followed by formation of the TTSS translocator
pore which requires the IpaB, IpaC and IpaD effectors
[5,57]. IpaB in particular induces apoptosis in host
macrophages leading to inflammatory infection [58].
Several of the Ipa proteins (IpaA/B/C/D) were increased
in vivo, while other TTSS effectors were either increased
or detected solely in vivo (IpaJ, IpgD, IcsB, OspC2,
OspC3, OspF, VirA). Additional plasmid-encoded pro-
teins such as PhoN1 and PhoN2 were decreased in
abundance in vivo. PhoN2 was reported to hydrolyze
dNTPs and modulate the localization of IcsA at the bac-
terial cell surface [59]. OspC2, IpaB and VirB were iden-
tified as immunogenic when probed with a piglet
antiserum in a 2D Western blot [15], suggesting that
these proteins could form potential vaccine targets for
the prevention of shigellosis. The Ipa proteins are
known to be transiently associated with the cell surface
and therefore are likely to contribute to the altered SD1
cell surface in the host gut environment. We assume
that other proteins likely secreted via the TTSS (OspC2,
OspC3) are at least transiently cell surface associated.
Abundance changes of the TTSS virulence factors corre-
lated well with the altered changes in the OM/cell sur-
face proteins in vivo. We are tempted to speculate that
the previously mentioned OM remodeling efforts benefit
the adaptation of SD1 to the host cell invasion process
via enhanced abundance of TTSS effectors in the cell
envelope. However, our data do not support uniformly
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increased abundances of all detected TTSS proteins in
the SD1 cell envelope in vivo.
The virulence of Shigella species is of the order S. dys-
enteriae >S. flexneri >S. sonnei >S. boydii. SD1 infection
has a limited diarrheal phase with a sudden onset of
acute dysentery, which could be explained by the expres-
sion of the potent virulence factor Shiga toxin (Stx) [14].
Shiga toxin subunit A (StxA) was detected only in vitro,
while Shiga toxin subunit B (StxB) was detected both in
vitro and in vivo, with StxB increased in abundance in
vitro. As Stx is a secretory protein [14], the abundance
levels of this protein are not readily obvious from proteo-
mic profiling of cell lysates. It is of interest to examine
whether the Shigella T2SS secretes other virulence fac-
tors in addition to the Shiga toxin. T2SS subunits were of
very low abundance in SD1 cells according to this survey.
Other proteins involved in Shigella pathogenicity are
the O-antigens which are highly diverse with at least 46
observed serotypes [2]. The variability of the O-antigens
has been brought into context with evasion of the host
immune system [60]. The small SD1 plasmid-encoded
galactosyltransferase RfpB involved in the O-antigen bio-
synthesis was detected only in vivo, while other enzymes
such as RfaD were increased in vivo. Enzymes potentially
known to contribute monosaccharides (galactose and
rhamnose) to the biosynthesis of the O-antigen sugars
were also increased in vivo, including LacZ, GalE/K/M/T,
RfbC, MelA, ManA and KdsB. Further studies are neces-
sary to determine whether increased carbohydrate meta-
bolism is functionally coupled to altered biosynthesis of
O-antigen sugars under in vivo conditions.
Conclusions
The comparative global proteomic survey of S. dysenter-
iae strain Sd1617 grown in vitro vs. S. dysenteriae cells
isolated from an infected host animal model (in vivo)
revealed abundance increases of several TTSS proteins
and effectors under in vivo conditions. Virulence pro-
teins such as OspC2 and IpaB, increased in abundance
in vivo, were previously determined to be immunogenic,
indicating their potential as vaccine candidates to com-
bat shigellosis. Proteins important for the structural
integrity of the bacterial cell wall and outer membrane
such as OM proteins, lipoproteins, and chaperones for
the cell envelope structures were decreased in vivo, indi-
cating morphological changes in the bacterial cell wall.
This hypothesis needs to be explored further in the con-
text of infection, pathogenicity and protection from host
factors. Proteins involved in response to anaerobic and
nutrient deficient conditions, oxidative stress and acid
stress were increased in vivo, reflecting the importance
of the biochemical processes permitting the survival of
the pathogen in the complex host gut environment.
Further characterization of proteins increased in
abundance in vivo will contribute to the understanding
of host-pathogen interactions and facilitate the design of
new vaccine candidates. It remains to be determined
how the absence of microflora in the intestinal milieu
might impact these observations.
Additional material
Additional file 1: Table S1. Protein abundance estimates from APEX
quantitation. APEX abundance values of 1761 S. dysenteriae serotype 1
(SD1) in vitro and in vivo proteins quantitated at a <5% false discovery
rate using the APEX Quantitative Proteomics Tool are listed along with
their pi, ni, and Oi values. The corresponding gene names, locus tags,
physicochemical properties and subcellular localizations are also listed in
the table.
Additional file 2: Table S2. SD1 differential protein expression statistical
analysis using Z-test and SAM. SD1 proteins listed in blue are
upregulated under in vitro conditions. For the two tailed Z-test, SD1
proteins differentially expressed at 99% confidence are listed; for the two
class SAM test, proteins differentially expressed at <10% FDR are listed.
Additional file 3: Table S3. APEX abundance values of SD1 in vitro and
in vivo biological replicates. Three biological replicates from both in vitro
and in vivo SD1 groups were analyzed as three to five technical
replicates to expand the scope of the analysis; their APEX abundance
values are listed.
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APEX: absolute protein expression; CM: cytoplasmic membrane; LPS:
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